openPR Logo
Press release

U.S. Blood Transfusion Diagnostics Market Size, Trends, Growth, Opportunities | Grifols, S.A., F. Hoffmann-La Roche Ltd, and QuidelOrtho Corporation

12-06-2024 07:15 AM CET | Health & Medicine

Press release from: Fortune Business Insights

U.S. Blood Transfusion Diagnostics Market

U.S. Blood Transfusion Diagnostics Market

The U.S. blood transfusion diagnostics market was valued at USD 1.91 billion in 2021 and is projected to grow from USD 2.20 billion in 2022 to USD 3.58 billion by 2029, recording a CAGR of 7.2% during the forecast period.

The U.S. Blood Transfusion Diagnostics Market is witnessing remarkable growth, driven by advancements in diagnostic technologies, increasing demand for safe blood transfusions, and stringent regulatory standards. The market focuses on ensuring safety and accuracy in blood grouping, screening, and compatibility testing, vital for patient outcomes in critical care scenarios.

๐——๐—ถ๐˜€๐—ฐ๐—ผ๐˜ƒ๐—ฒ๐—ฟ ๐—ช๐—ต๐—ฎ๐˜ ๐—ฌ๐—ผ๐˜‚'๐—ฟ๐—ฒ ๐— ๐—ถ๐˜€๐˜€๐—ถ๐—ป๐—ด: ๐—š๐—ฒ๐˜ ๐—ฎ ๐—™๐—ฟ๐—ฒ๐—ฒ ๐—ฅ๐—ฒ๐—ฝ๐—ผ๐—ฟ๐˜ (๐—ฃ๐——๐—™) ๐—ฆ๐—ฎ๐—บ๐—ฝ๐—น๐—ฒ: https://www.fortunebusinessinsights.com/enquiry/sample/u-s-blood-transfusion-diagnostics-market-107024

๐—ž๐—ฒ๐˜† ๐—œ๐—ป๐—ฑ๐˜‚๐˜€๐˜๐—ฟ๐˜† ๐——๐—ฒ๐˜ƒ๐—ฒ๐—น๐—ผ๐—ฝ๐—บ๐—ฒ๐—ป๐˜

In June 2022, Alba Bioscience Limited (QUOTIENT LIMITED) achieved a significant milestone by receiving USFDA approval for its ORTHO Sera and ALBAclone blood grouping reagents. This approval underscores the company's commitment to advancing transfusion diagnostics and ensuring reliable and accurate blood grouping solutions in the U.S.

๐—ง๐—ผ๐—ฝ ๐—–๐—ผ๐—บ๐—ฝ๐—ฎ๐—ป๐—ถ๐—ฒ๐˜€ ๐—ถ๐—ป ๐˜๐—ต๐—ฒ ๐—จ.๐—ฆ. ๐—•๐—น๐—ผ๐—ผ๐—ฑ ๐—ง๐—ฟ๐—ฎ๐—ป๐˜€๐—ณ๐˜‚๐˜€๐—ถ๐—ผ๐—ป ๐——๐—ถ๐—ฎ๐—ด๐—ป๐—ผ๐˜€๐˜๐—ถ๐—ฐ๐˜€ ๐— ๐—ฎ๐—ฟ๐—ธ๐—ฒ๐˜

โ€ข QUOTIENT LIMITED (Switzerland)
โ€ข Grifols, S.A. (Spain)
โ€ข Immucor, Inc. (U.S.)
โ€ข Bio-Rad Laboratories, Inc. (U.S.)
โ€ข Merck KGaA (Germany)
โ€ข Beckman Coulter, Inc. (Danaher) (U.S.)
โ€ข QuidelOrtho Corporation (U.S.)
โ€ข F. Hoffmann-La Roche Ltd. (Switzerland)
โ€ข Abbott (U.S.)

๐— ๐—ฎ๐—ฟ๐—ธ๐—ฒ๐˜ ๐——๐—ฟ๐—ถ๐˜ƒ๐—ฒ๐—ฟ๐˜€

๐—œ๐—ป๐—ฐ๐—ฟ๐—ฒ๐—ฎ๐˜€๐—ถ๐—ป๐—ด ๐——๐—ฒ๐—บ๐—ฎ๐—ป๐—ฑ ๐—ณ๐—ผ๐—ฟ ๐—ฆ๐—ฎ๐—ณ๐—ฒ ๐—•๐—น๐—ผ๐—ผ๐—ฑ ๐—ง๐—ฟ๐—ฎ๐—ป๐˜€๐—ณ๐˜‚๐˜€๐—ถ๐—ผ๐—ป๐˜€

The rising number of surgical procedures, trauma cases, and chronic diseases has amplified the need for safe and efficient blood transfusion diagnostics. Accurate blood screening and compatibility testing play a pivotal role in minimizing transfusion-related complications.

๐—ง๐—ฒ๐—ฐ๐—ต๐—ป๐—ผ๐—น๐—ผ๐—ด๐—ถ๐—ฐ๐—ฎ๐—น ๐—”๐—ฑ๐˜ƒ๐—ฎ๐—ป๐—ฐ๐—ฒ๐—บ๐—ฒ๐—ป๐˜๐˜€ ๐—ถ๐—ป ๐——๐—ถ๐—ฎ๐—ด๐—ป๐—ผ๐˜€๐˜๐—ถ๐—ฐ๐˜€

Innovations such as automated blood screening systems, next-generation sequencing, and AI-driven diagnostic tools are enhancing the precision and speed of blood transfusion processes, boosting market growth.

๐—ฆ๐˜๐—ฟ๐—ถ๐—ป๐—ด๐—ฒ๐—ป๐˜ ๐—ฅ๐—ฒ๐—ด๐˜‚๐—น๐—ฎ๐˜๐—ผ๐—ฟ๐˜† ๐—ฆ๐˜๐—ฎ๐—ป๐—ฑ๐—ฎ๐—ฟ๐—ฑ๐˜€

The U.S. government and healthcare agencies impose strict regulations on blood screening and transfusion practices, encouraging the adoption of advanced diagnostic technologies to meet compliance and safety standards.

๐— ๐—ฎ๐—ฟ๐—ธ๐—ฒ๐˜ ๐—ฅ๐—ฒ๐˜€๐˜๐—ฟ๐—ฎ๐—ถ๐—ป๐˜๐˜€

๐—›๐—ถ๐—ด๐—ต ๐—–๐—ผ๐˜€๐˜๐˜€ ๐—ผ๐—ณ ๐——๐—ถ๐—ฎ๐—ด๐—ป๐—ผ๐˜€๐˜๐—ถ๐—ฐ ๐—˜๐—พ๐˜‚๐—ถ๐—ฝ๐—บ๐—ฒ๐—ป๐˜

The significant investment required for advanced diagnostic equipment and reagents poses a challenge for smaller healthcare facilities, potentially limiting market penetration.

๐—ฆ๐—ต๐—ผ๐—ฟ๐˜๐—ฎ๐—ด๐—ฒ ๐—ผ๐—ณ ๐—ฆ๐—ธ๐—ถ๐—น๐—น๐—ฒ๐—ฑ ๐—ง๐—ฒ๐—ฐ๐—ต๐—ป๐—ถ๐—ฐ๐—ถ๐—ฎ๐—ป๐˜€

The lack of adequately trained professionals to operate sophisticated diagnostic tools and interpret results accurately remains a critical barrier to market growth.

๐— ๐—ฎ๐—ฟ๐—ธ๐—ฒ๐˜ ๐—ฅ๐—ฒ๐—ฝ๐—ผ๐—ฟ๐˜ ๐—–๐—ผ๐˜ƒ๐—ฒ๐—ฟ๐—ฎ๐—ด๐—ฒ

The market report provides an in-depth U.S. Blood Transfusion Diagnostics Market analysis, including a detailed assessment of key drivers, restraints, competitive landscape, regional insights, and segment performance. It also explores future growth opportunities and technological advancements shaping the industry.

๐—™๐—ผ๐—ฟ ๐—™๐˜‚๐—น๐—น ๐—ฅ๐—ฒ๐—ฝ๐—ผ๐—ฟ๐˜ ๐—–๐—ผ๐˜ƒ๐—ฒ๐—ฟ๐—ฎ๐—ด๐—ฒ ๐—ฉ๐—ถ๐˜€๐—ถ๐˜: https://www.fortunebusinessinsights.com/u-s-blood-transfusion-diagnostics-market-107024

๐— ๐—ฎ๐—ฟ๐—ธ๐—ฒ๐˜ ๐—–๐—ผ๐—บ๐—ฝ๐—ฒ๐˜๐—ถ๐˜๐—ถ๐˜ƒ๐—ฒ ๐—Ÿ๐—ฎ๐—ป๐—ฑ๐˜€๐—ฐ๐—ฎ๐—ฝ๐—ฒ

Leading players such as Grifols, Immucor, and Bio-Rad Laboratories are investing significantly in R&D and strategic collaborations to expand their market share. A focus on innovation, regulatory compliance, and cost-effectiveness drives the competition.

๐— ๐—ฎ๐—ฟ๐—ธ๐—ฒ๐˜ ๐—ฆ๐—ฒ๐—ด๐—บ๐—ฒ๐—ป๐˜๐˜€

๐—•๐—น๐—ผ๐—ผ๐—ฑ ๐—ฆ๐—ฐ๐—ฟ๐—ฒ๐—ฒ๐—ป๐—ถ๐—ป๐—ด ๐—ฆ๐—ฒ๐—ด๐—บ๐—ฒ๐—ป๐˜ ๐—Ÿ๐—ฒ๐—ฎ๐—ฑ๐—ถ๐—ป๐—ด ๐˜๐—ต๐—ฒ ๐— ๐—ฎ๐—ฟ๐—ธ๐—ฒ๐˜

The blood screening segment is expected to dominate the market during the forecast period, fueled by the increasing prevalence of infectious diseases and the need for accurate donor screening to prevent transfusion-transmitted infections (TTIs).

๐—–๐—ผ๐—บ๐—ฝ๐—ฎ๐˜๐—ถ๐—ฏ๐—ถ๐—น๐—ถ๐˜๐˜† ๐—ง๐—ฒ๐˜€๐˜๐—ถ๐—ป๐—ด ๐—ฆ๐—ฒ๐—ด๐—บ๐—ฒ๐—ป๐˜ ๐—ฆ๐—ต๐—ผ๐˜„๐—ถ๐—ป๐—ด ๐—ฆ๐˜๐—ฟ๐—ผ๐—ป๐—ด ๐—š๐—ฟ๐—ผ๐˜„๐˜๐—ต

Compatibility testing, including crossmatching and antibody screening, is gaining traction due to its critical role in ensuring transfusion safety and reducing adverse reactions.

๐— ๐—ฎ๐—ฟ๐—ธ๐—ฒ๐˜ ๐—ฅ๐—ฒ๐—ด๐—ถ๐—ผ๐—ป๐—ฎ๐—น ๐—œ๐—ป๐˜€๐—ถ๐—ด๐—ต๐˜๐˜€

The U.S. leads the global blood transfusion diagnostics market due to its robust healthcare infrastructure, advanced diagnostic technologies, and supportive government initiatives. Major metropolitan regions such as New York, Los Angeles, and Chicago drive demand, while rural areas present opportunities for market expansion with increased healthcare investments.

๐—™๐˜‚๐˜๐˜‚๐—ฟ๐—ฒ ๐— ๐—ฎ๐—ฟ๐—ธ๐—ฒ๐˜ ๐—ฆ๐—ฐ๐—ผ๐—ฝ๐—ฒ

โ€ข Development of portable and point-of-care blood transfusion diagnostic devices for faster and more accessible testing.
โ€ข Integration of AI and big data analytics to improve diagnostic accuracy and streamline transfusion workflows.
โ€ข Focus on cost-effective solutions to enhance market penetration in underserved regions.
โ€ข Advancements in molecular diagnostics for comprehensive and precise blood screening.

๐—–๐—ผ๐—ป๐—ฐ๐—น๐˜‚๐˜€๐—ถ๐—ผ๐—ป

The U.S. Blood Transfusion Diagnostics Market is poised for significant growth, driven by technological innovations, rising demand for safe transfusions, and supportive regulatory frameworks. With leading companies investing in cutting-edge solutions, the market is set to advance healthcare outcomes while addressing challenges related to cost and accessibility.

For more information, explore the U.S. Blood Transfusion Diagnostics Market Report.

๐—–๐˜‚๐˜€๐˜๐—ผ๐—บ๐—ถ๐˜‡๐—ฒ ๐—ง๐—ต๐—ถ๐˜€ ๐—ฅ๐—ฒ๐—ฝ๐—ผ๐—ฟ๐˜ ๐—”๐—ฐ๐—ฐ๐—ผ๐—ฟ๐—ฑ๐—ถ๐—ป๐—ด ๐—ง๐—ผ ๐—ฌ๐—ผ๐˜‚๐—ฟ ๐—–๐—ผ๐—ป๐˜ƒ๐—ฒ๐—ป๐—ถ๐—ฒ๐—ป๐—ฐ๐—ฒ: https://www.fortunebusinessinsights.com/enquiry/ask-for-customization/u-s-blood-transfusion-diagnostics-market-107024

๐—–๐—ผ๐—ป๐˜๐—ฎ๐—ฐ๐˜ ๐—จ๐˜€:
Fortune Business Insightsโ„ข Pvt. Ltd.
9th Floor, Icon Tower,
Baner, Pune-411045,
Maharashtra, India.
Phone:
U.S.:+1 833 909 2966 (Toll-Free)
U.K.: +44 808 502 0280 (Toll-Free)
APAC +91 744 740 1245
Email: sales@fortunebusinessinsights.com

๐€๐›๐จ๐ฎ๐ญ ๐”๐ฌ:
Fortune Business Insightsโ„ข offers expert corporate analysis and accurate data, helping organizations make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release U.S. Blood Transfusion Diagnostics Market Size, Trends, Growth, Opportunities | Grifols, S.A., F. Hoffmann-La Roche Ltd, and QuidelOrtho Corporation here

News-ID: 3775128 • Views: โ€ฆ

More Releases from Fortune Business Insights

Used Cooking Oil Market Size, Share, Growth, Trends, 2032
Used Cooking Oil Market Size, Share, Growth, Trends, 2032
๐Œ๐š๐ซ๐ค๐ž๐ญ ๐Ž๐ฏ๐ž๐ซ๐ฏ๐ข๐ž๐ฐ: The global used cooking oil market size was USD 7.09 billion in 2023 and is projected to grow from USD 7.54 billion in 2024 to USD 13.96 billion by 2032 at a CAGR of 8.00% during the forecast period (2024-2032). UCOs are fats and oils reused after processing for cooking or frying in food processing restaurants, industry, fast foods, and at the consumer level, in households. The impurity content, suchโ€ฆ
Doughnuts Market Size, Share, Growth, Trends, 2032
Doughnuts Market Size, Share, Growth, Trends, 2032
๐Œ๐š๐ซ๐ค๐ž๐ญ ๐Ž๐ฏ๐ž๐ซ๐ฏ๐ข๐ž๐ฐ: The global doughnuts market size was USD 10.84 billion in 2023. The market is projected to expand from USD 11.22 billion in 2024 to USD 15.12 billion by 2032, exhibiting a CAGR of 3.79% during the forecast period. A doughnut, a small ring-shaped confection, is prepared by frying or baking leavened dough, offering a sweet indulgence. Increasing consumer demand for healthier options prompts brands to introduce innovative products, aligning withโ€ฆ
Honey Market Size, Share, Growth, Trends, 2032
Honey Market Size, Share, Growth, Trends, 2032
๐Œ๐š๐ซ๐ค๐ž๐ญ ๐Ž๐ฏ๐ž๐ซ๐ฏ๐ข๐ž๐ฐ The global honey market size was valued at USD 8.94 billion in 2023 and is projected to grow from USD 9.40 billion in 2024 to USD 15.59 billion by 2032, exhibiting a CAGR of 6.52% during the forecast period 2024-2032. Rising demand for organic and healthy alternatives to sugar to propel market growth. Fortune Business Insightsโ„ข provides this information in its report titled "Honey Market, 2024-2032." ๐†๐ž๐ญ ๐€ ๐…๐ซ๐ž๐ž ๐’๐š๐ฆ๐ฉ๐ฅ๐žโ€ฆ
Pasta Market Size, Share, Growth, 2032
Pasta Market Size, Share, Growth, 2032
๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐Ž๐ฏ๐ž๐ซ๐ฏ๐ข๐ž๐ฐ: The global pasta market size was valued at USD 68.35 billion in 2023 and is projected to grow from USD 71.42 billion in 2024 to USD 100.24 billion by 2032, exhibiting a CAGR of 5.47% during the forecast period of 2024-2032. Pasta is a largely consumed, easy-to-make, and an affordable food product. The increasing and regular evolution of pasta propels the pasta market growth during the forecast period. The risingโ€ฆ

All 5 Releases


More Releases for Blood

Medical Blood Bag Market 2027 Global Analysis and Forecasts by Type (Single Bloo โ€ฆ
The medical blood bags are the instruments that are used to store, collect, transport, and transfuse blood and its components. The disposable blood bags replaced the use of glass bottles due to problems associated with the use of glass bottles including insufficient sterility, leading to contamination of the blood, and the development of air bubbles resulted in severe complications during blood transfusion. Access Sample Report@: https://bit.ly/3rGMS4Q Leading Players in theโ€ฆ
Global Blood coagulation analyzer Market, Blood coagulation analyzer Market 2020 โ€ฆ
The Blood coagulation analyzer market report provides a comprehensive view of global Blood coagulation analyzer industry. The study provides the industry overview with its growth analysis including CAGR, market shares, sales, gross margin, value, future trends, market opportunities etc. The study also includes analysis of historic data from 2015 to 2019 along with forecast from 2020 to 2025. Further, the Blood coagulation analyzer report contains drivers andrestraints of Blood coagulationโ€ฆ
Blood Bank (Blood Banking) Market 2019 Analysis By American Red Cross, Japan Red โ€ฆ
According to this study, over the next five years the Blood Bank (Blood Banking) market will register a 7.7% CAGR in terms of revenue, the global market size will reach US$ 40500 million by 2024, from US$ 26000 million in 2019. Blood Bank (Blood Banking) Market reports also offer important insights which help the industry experts, product managers, CEOs, and business executives to draft their policies on various parameters including expansion,โ€ฆ
Blood Bank (Blood Banking) Market 2019 Analysis By American Red Cross, Japan Red โ€ฆ
โ€œBlood Bank (Blood Banking)โ€ Market research report covers the data which is helpful for key players, product scope, market overview, market opportunities, market risk, market driving force, technological advancement, distributors, traders, dealers, research findings. These data representations provide predictive data regarding the future estimations for convincing market growth. According to this study, over the next five years the Blood Bank (Blood Banking) market will register a 7.7% CAGR in terms ofโ€ฆ
Blood Bank (Blood Banking) Market Key Player Analysis By New York Blood Center, โ€ฆ
Over the next five years Blood Bank (Blood Banking) will register a 7.7% CAGR in terms of revenue, reach US$ 40500 million by 2023, from US$ 26000 million in 2017. Global Blood Bank (Blood Banking) Market 2018 peaks the detailed analysis of industry share, growth factors, development trends, size, majors manufacturers and 2025 forecast. The report also analyze innovative business strategies, value added factors and business opportunities. The Blood Bank (Bloodโ€ฆ
Blood Group Typing Market Banks on Increasing Need for Blood, Blood Products, an โ€ฆ
The global blood group typing market is foreseen to garner a massive demand in the foreseeable future owing to certain factors such as the rising demand for blood and blood products. Nonetheless, the market growth could see an escalation on the back of other factors such as increasing prenatal testing which requires blood grouping, mounting count of road mishaps and trauma incidences requiring blood transfusion, and increasing application in forensicโ€ฆ